A New Tool for Diagnosing Cancer

New results published in Nature Cancer detail a proof-of-principle study of Orion, a new imaging tool developed by a team at the LSP and RareCyte, Inc. Orion serves as a bridge between the histology, the standard-of-care method for diagnosing tumors in the clinic, and high-plex imaging methods that provide rich molecular details about cell types and states. Orion could help usher in a new era for pathology, where pathologists use Orion in the clinic to inform disease diagnosis and treatment.

READ MORE IN HMS NEWS